FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pulmonology, and may be used in treating the patients with cold bronchospasm and mucosal oedema in the patients with cold bronchial asthma. That is ensured by 2-3 inhalations of berodual and simbicort before walking in the open air at temperature (-20°C)-(-45°C).
EFFECT: method provides arrest of cold bronchospasm ensured by the prescribed dose schedule of the antasthmatics ensuring passability of both bronchial tubes, and the whole airway completely.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PROLONGED PREVENTION OF COLD BRONCHOSPASM IN PATIENTS SUFFERING MIXED PATHOLOGY | 2011 |
|
RU2460547C1 |
| METHOD OF DIAGNOSTICS OF COLD-INDUCED BRONCHIAL ASTHMA | 2007 |
|
RU2361514C1 |
| METHOD FOR DIAGNOSTICS OF COLD FORM OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2654577C2 |
| METHOD FOR TREATMENT OF ASTHMA | 2015 |
|
RU2611406C1 |
| DIAGNOSTIC BRONCHOALVEOLAR LAVAGE TECHNIQUE | 2007 |
|
RU2417733C2 |
| METHOD FOR DIAGNOSING COLD AIRWAY HYPERREACTIVITY IN PATIENTS WITH BRONCHIAL ASTHMA | 2022 |
|
RU2794850C1 |
| METHOD FOR PREDICTION OF COLD AIRWAY HYPERREACTIVITY CORRECTION EFFICIENCY IN BRONCHIAL ASTHMA PATIENTS WITH APPLICATION OF EXTRA-FINE AEROSOL FOR INHALATIONS OF BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE | 2019 |
|
RU2721415C1 |
| METHOD OF DIAGNOSTICS OF ALLERGIC FORM OF BRONCHIAL ASTHMA IN CHILDREN UNDER 5 | 2016 |
|
RU2647195C1 |
| METHOD OF THE DIFFERENTIAL DIAGNOSIS OF ISOLATED COLD AND COMBINED COLD AND OSMOTIC AIRWAY HYPERREACTIVITY IN PATIENTS WITH BRONCHIAL ASTHMA | 2022 |
|
RU2802142C1 |
| METHOD FOR TREATING BRONCHIAL ASTHMA IN CHILDREN IN ATTACK PERIOD | 2002 |
|
RU2236219C2 |
